NASDAQ: BCTXZ BriaCell Therapeutics Corp. 8-K

BriaCell raises $4.71M through sale of 1.45M shares at $3.25, diluting existing holders

Filed June 3, 2026 · Period ending May 31, 2026 · ~1 min read

Key Changes

  • high

    Company sold 1.45 million shares at $3.25 each, raising $4.71M gross proceeds before fees. Funds will support working capital and business objectives. Offering closed June 2, 2026.

  • medium

    Placement agent ThinkEquity received 7.5% cash fee (~$353K) plus warrants to buy 72,465 shares at $4.0625 (25% premium to offering price), exercisable immediately for five years.

  • medium

    Shares sold under existing shelf registration from January 2024. Placement agent warrants issued as private placement, not registered, representing additional 5% dilution versus shares sold.

This preview is just the start — the full report includes the narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.

Read 3 full reports/month free No card required. Takes 30 seconds.

Want to see a complete report first? Today's free report (HOTH 10-Q) is open in full — no account needed.

Partner

Trade BCTXZ commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Generated by AI · Jun 10, 2026 6:57 PM